- 专利标题: NEW FORMULATIONS COMPRISING BIOLOGIC ACTIVE DRUGS
-
申请号: US18568363申请日: 2022-06-10
-
公开(公告)号: US20240277624A1公开(公告)日: 2024-08-22
- 发明人: Anders JOHANSSON , Mårten ROOTH , Erik LINDAHL , Joel HELLRUP , Jonas FRANSSON , David WESTBERG , Otto SKOLLING
- 申请人: NANEXA AB
- 申请人地址: SE Uppsala
- 专利权人: NANEXA AB
- 当前专利权人: NANEXA AB
- 当前专利权人地址: SE Uppsala
- 优先权: GB 08282.1 2021.06.10
- 国际申请: PCT/GB2022/051461 2022.06.10
- 进入国家日期: 2023-12-08
- 主分类号: A61K9/50
- IPC分类号: A61K9/50 ; A61K9/00 ; A61K9/10 ; A61K9/51 ; A61K38/00 ; C23C16/40 ; C23C16/44 ; C23C16/455
摘要:
There is provided a pharmaceutical formulation that is useful in delivering a biologic active drug in a high dose, comprising a plurality of particles suspended in an aqueous carrier system, which particles: pharmaceutical formulation, comprising a plurality of particles suspended in a carrier system, which particles: (a) have a weight-, number-, or volume-based mean diameter that is between amount 10 nm and about 700 pm; and (b) comprise solid cores comprising a biologic active drug, coated, at least in part, by a coating of inorganic material, and wherein the formulation comprises a concentration of said biologic active drug of at least 10 mg/ml. Preferred biologic active drug include immunoglobulins, monoclonal antibodies, antibody mimetics, cytokines and cytokine antagonists, and human peptide hormones.
信息查询